General Information of the Compound
Compound ID |
CP0470852
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-[(2S,5S,8S,11R,14S)-8-benzyl-14-[3-(diaminomethylideneamino)propyl]-11-[(4-hydroxyphenyl)methyl]-1,7-dimethyl-5-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propylurea
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C45H56N10O7
|
||||||||||||||||||
Molecular Weight |
849.006
|
||||||||||||||||||
Canonical SMILES |
CN1[C@@H](CCCNC(N)=O)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(N)=N)C1=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C45H56N10O7/c1-54-37(15-9-23-50-45(48)62)40(58)53-36(26-30-16-19-31-12-6-7-13-32(31)24-30)43(61)55(2)38(27-28-10-4-3-5-11-28)41(59)52-35(25-29-17-20-33(56)21-18-29)39(57)51-34(42(54)60)14-8-22-49-44(46)47/h3-7,10-13,16-21,24,34-38,56H,8-9,14-15,22-23,25-27H2,1-2H3,(H,51,57)(H,52,59)(H,53,58)(H4,46,47,49)(H3,48,50,62)/t34-,35+,36-,37-,38-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
HIILIQMWCQCLLY-VNACGOBZSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04108, Atypical chemokine receptor 3
Protein ID: PT02059, C-X-C chemokine receptor type 4